Understanding and manipulating immune responses is critical for successful tissue regeneration. Immunotherapy & immune engineering explores how engineered immune cells and modulatory agents enhance tissue repair, prevent graft rejection, and support integration of bioengineered constructs. Researchers are developing immune-compatible scaffolds and combining stem cell technologies with immune checkpoint modulation to achieve lasting outcomes. Engineered T cells, regulatory macrophages, and cytokine delivery systems are now being applied to modulate inflammation and direct healing. The integration of immune engineering with regenerative platforms also contributes to resolving chronic inflammation and improving scaffold longevity. Immunotherapy & immune engineering continues to evolve into a cornerstone of precision regeneration, offering targeted solutions for both autoimmune and degenerative conditions.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : Keratin-TMAO wound dressing promote tissue recovery in diabetic rats via activation of M2 macrophages
Marek Konop, Medical University of Warsaw, Poland
Title : Assessing geometric simplifications in vertebral modeling for reliable numerical analysis of intervertebral discs
Oleg Ardatov, Vilnius University, Lithuania